Remission InductionRemission, SpontaneousCytarabineAsparaginaseDaunorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteRecurrence6-MercaptopurineVincristineAntineoplastic Combined Chemotherapy ProtocolsMethotrexateTreatment OutcomeThioguanineIdarubicinPrednisoneLeukemia, MyeloidLeukemia, LymphoidPrognosisCyclophosphamideDisease-Free SurvivalAcute DiseaseNeoplasm, ResidualLeukemia, Promyelocytic, AcuteLeukemiaBone MarrowCombined Modality TherapyBone Marrow TransplantationEtoposideTime FactorsPrednisoloneDoxorubicinEnzyme InductionDrug Administration ScheduleSurvival AnalysisFollow-Up StudiesDrug Therapy, CombinationBlast CrisisAntineoplastic AgentsTransplantation, HomologousHematopoietic Stem Cell TransplantationSurvival RateLeukocyte CountRetrospective StudiesClinical Trials as TopicPlatelet CountAntibodies, MonoclonalProspective StudiesDexamethasoneInjections, SpinalDisseminated Intravascular CoagulationTransplantation, AutologousImmunosuppressive AgentsNephrotic SyndromeSalvage TherapyMesalamineColitis, UlcerativeAge FactorsNeoplasm Recurrence, LocalHodgkin DiseaseAntibodies, Monoclonal, Murine-DerivedLymphoma, Non-HodgkinAntirheumatic AgentsCrohn DiseaseRNA, MessengerGraft vs Host DiseaseSeverity of Illness IndexLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ConditioningInduction ChemotherapyDose-Response Relationship, DrugWegener GranulomatosisArthritis, RheumatoidDepressive Disorder, MajorCells, CulturedActuarial AnalysisBleomycinMelphalanDisease ProgressionProcarbazineWhole-Body IrradiationGlucocorticoidsVidarabineCladribineMultiple MyelomaAminosalicylic AcidsMechlorethamineApoptosisAnti-Inflammatory AgentsLymphoma, FollicularBone Marrow PurgingAzathioprineLymphomaPituitary ACTH HypersecretionCyclosporineEmbryonic InductionGastrointestinal AgentsLeukemic InfiltrationSignal TransductionImmunologic Factors